Cleared Traditional

K153117 - AESKUSLIDES ANA HEp-2-Gamma

K153117 is an FDA 510(k) clearance for AESKUSLIDES ANA HEp-2-Gamma, manufactured by Aesku Systems GmbH&Co.Kg. The device is a Class 2 Immunology device with product code DHN cleared through the Traditional 510(k) pathway after a 274-day FDA review.

K153117 · Aesku Systems GmbH&Co.Kg · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
274d
Days
Class 2
Risk

K153117 is an FDA 510(k) clearance for the AESKUSLIDES ANA HEp-2-Gamma, HELIOS FULLY AUTOMATED IFA SYSTEM. Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Aesku Systems GmbH&Co.Kg (Wendelsheim, DE). The FDA issued a Cleared decision on July 28, 2016 after a review of 274 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Aesku Systems GmbH&Co.Kg devices

FDA 510(k) Submission Details - K153117

510(k) Number K153117 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2015
Decision Date July 28, 2016
Days to Decision 274 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
170d slower than avg
Panel avg: 104d · This submission: 274d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHN Device Classification - Class 2, Special Controls

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 63
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K153117.
Zeus IFA ANA HEp-2 Test System, Zeus dIFine
K201956 · Zeus Scientific, Inc. · Apr 2022
ImmuGlo HEp-2 Elite IFA
K172745 · Immco Diagnostics, Inc. · Jun 2018
EUROIMMUN IFA 40: HEP-20-10
K141827 · Euroimmun Us, Inc. · Apr 2015
NOVA Lite DAPI ANA Kit
K150155 · Inova Diagnostics, Inc. · Apr 2015
RHIGENE HEP-ANA TEST SYSTEM
K042680 · Corgenix, Inc. · Nov 2004
LIQUICHEK AUTOIMMUNE NEGATIVE CONTROL, CATALOG #130
K024220 · Bio-Rad · Jan 2003